Cancer Center Business Cancer Center Business Summit Introduction - - PDF document

▶
cancer center business cancer center business summit
SMART_READER_LITE
LIVE PREVIEW

Cancer Center Business Cancer Center Business Summit Introduction - - PDF document

Nov 07, 2023 516 likes •616 views

Cancer Center Business Cancer Center Business Summit Introduction Summit Introduction Michael L. Blau, Esq. Foley & Lardner LLP Sponsors Sponsors Platinum Abraxis Oncology Aptium Oncology Bayer HealthCare Pharmaceuticals,

slide-1
SLIDE 1

1

Cancer Center Business Cancer Center Business Summit Introduction Summit Introduction

Michael L. Blau, Esq. Foley & Lardner LLP

2

Sponsors Sponsors

Platinum

  • Abraxis Oncology
  • Aptium Oncology
  • Bayer HealthCare Pharmaceuticals, Inc.
  • HealthCare Appraisers, Inc.
  • IMPAC Medical Systems, Inc.
  • Lilly Oncology
  • Net.Orange, Inc.
  • Onyx Pharmaceuticals
  • OTN
  • PricewaterhouseCoopers LLP
  • US Oncology
slide-2
SLIDE 2

2

3

Sponsors Sponsors

Gold

  • D3 Radiation Planning Services
  • Genentech BioOncology
  • MarCap Corporation

Silver

  • GlaxoSmithKline Oncology
  • MGI Pharma, Inc.
  • Novartis Oncology
  • Oncology Supply
  • Shattuck Hammond Partners
  • Sullivan, Cotter & Associates, Inc.
  • Varian Medical Systems

4

Sponsors Sponsors

Bronze

  • Myriad Genetic Laboratories
  • Oncology Management Consulting Group
  • Physicians Total Care

In-Kind

  • Hematology & Oncology News & Issues
slide-3
SLIDE 3

3

5

Introduction Introduction

<50 50-64 >65 Total 2000 2010

188K 187K 361K 508K 754K 857K 1.3M 1.6M 23% Increase in projected cancer care 23% Increase in projected cancer care Source: National Cancer Institute

Growth in Market Demand

6

Introduction Introduction

Demand Growth Driven by Demographics and…

500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 2000 2010 2020 2030 2040 2050 85+ 75-84 65-74 50-64 <50 Source: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Public-Use Data (1975-2002), National Cancer Institute

slide-4
SLIDE 4

4

7

Introduction Introduction

Improved Survivorship Rates

55% 46% 61% 55% 50% 60% 66% 66% 66%

0% 10% 20% 30% 40% 50% 60% 70% 1975-1979 1985-1989 1995-2002

Year of Diagnosis

Males and Females Males Females Survival Rate

Source: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Public-Use Data (1975-2002), National Cancer Institute

Five Year Relative Survival Rate by Gender

8

Background Background

Demand Presents Differing Inpatient and Outpatient Opportunities

0% 60% (60%) 0% 10% 20%

Net Margin Volume Growth, 2003-2008

Surgical Oncology – Inpatient Surgical Oncology – Outpatient Medical Oncology – Inpatient Radiation Oncology – Outpatient Oncology Imaging – Outpatient Source: The Advisory Board, Innovations Center Futures Database

slide-5
SLIDE 5

5

9

Introduction Introduction

Differing Business Opportunities by Tumor Site

Inpatient Growth by Tumor Site

0% 10% (10%) (30)% 10% 30%

Net Margin Volume Growth, 2003-2008

Thoracic ENT Gynecology Hematological Neuro GI-Other Prostate Bladder Breast Ortho Renal GI-Colorectal Source: The Advisory Board, Innovations Center Futures Database

10

Introduction Introduction

Differing Business Opportunities by Tumor Site

Outpatient Growth by Tumor Site

30% 50% (10%) (15)% 10% 15%

Net Margin Volume Growth, 2003-2008

Thoracic Hematological Neuro GI-Other Prostate Bladder Ortho Renal GI-Colorectal ENT Gynecology Breast Source: The Advisory Board, Innovations Center Futures Database

slide-6
SLIDE 6

6

11

Introduction New Business Introduction New Business Opportunities: Market Trends Opportunities: Market Trends

  • Rise of consumerism – quality and cost

imperatives

  • New information technologies
  • Shift from inpatient to outpatient/minimally

invasive

  • Reimbursement reductions for chemo

drugs, drug administration, and imaging

  • Health reform

12

Introduction Business Introduction Business Opportunities: New Technologies Opportunities: New Technologies

  • Gene therapy
  • Vaccine therapy/Oral chemotherapy
  • Molecular diagnostics
  • Proton Beam therapy
  • Robotic surgery
  • Gamma knife
  • Cyberknife
  • Stereotactic radiosurgery
  • IGRT
  • Virtual colonoscopy
  • 64-Slice CT
  • EMR and HIT
slide-7
SLIDE 7

7

13

Introduction New Business Introduction New Business Opportunities: Consumer/Retail Opportunities: Consumer/Retail

  • Community based clinical trials
  • Psycho-social programs
  • Alternative and complementary medicine programs
  • Survivorship programs
  • Concierge care/health coach programs
  • Palliative care
  • Home care
  • Pain management
  • Nutrition
  • Fitness and rehab
  • Family services
  • Reference library

14

Introduction Differing Business Introduction Differing Business Opportunities by Type of Providers Opportunities by Type of Providers

  • NCI Designated Centers
  • Academic Medical Centers
  • Community Hospitals
  • Community Cancer Centers
  • Medical Groups
  • Joint Ventures
  • Networks
slide-8
SLIDE 8

8

15

Introduction Introduction

  • Coverting opportunities to business

success is a challenge in cancer care

– Multi-modality – Multi-disciplinary – Multi-stakeholders – Multi-site – Multi-systems – Multi-expenses – Multi-risks

16

As we look to the future, what will be the best business models and practices to

  • rganize the multitude of stakeholders into

high quality effective, efficient and sustainable cancer care programs that meet patient needs in a humane and responsible manner?